qrl-101
Small moleculeexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 22, 2022 (NCT05667779)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06877624 | Phase 1 | Jan 10, 2025 | ICON, QurAlis Corporation |
| NCT06714396 | Phase 1 | Nov 11, 2024 | QurAlis Corporation |
| NCT06681441 | Phase 1 | Oct 7, 2024 | Leiden University, QurAlis Corporation |
| NCT06532396 | Phase 1 | Jul 1, 2024 | ICON, QurAlis Corporation |
| NCT05667779 | Phase 1 | Dec 22, 2022 | ICON, QurAlis Corporation |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| QurAlis Corporation | For profit | 5 | 5 | 1 | 2022 |
| ICON | For profit | 3 | 0 | 1 | 2022 |
| Leiden University | Academic/Hospital | 1 | 0 | 1 | 2024 |
3 organizations
Page 1 / 1